This topic contains a solution. Click here to go to the answer

Author Question: All of the following are grounds for objections to interrogatories except___________. A. It is a ... (Read 35 times)

809779

  • Hero Member
  • *****
  • Posts: 579
All of the following are grounds for objections to interrogatories except___________.
 
  A. It is a trade secret
  B. It is protected by the work product doctrine
  C. It harms the client's case
  D. It is protected by privilege
  E. All of the above

Question 2

An agency does not have the inherent authority to promulgate:
 
  a. procedural rules
  b. substantive rules
  c. interpretive rules
  d. None of the above. Agencies may never promulgate rules unless expressly authorized in the enabling statute.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hanadaa

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

C

Answer to Question 2

b




809779

  • Member
  • Posts: 579
Reply 2 on: Aug 3, 2018
:D TYSM


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library